Back to Search
Start Over
Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion.
- Source :
-
HemaSphere [Hemasphere] 2019 Jun 04; Vol. 3 (3), pp. e193. Date of Electronic Publication: 2019 Jun 04 (Print Publication: 2019). - Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 2572-9241
- Volume :
- 3
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- HemaSphere
- Publication Type :
- Report
- Accession number :
- 31723830
- Full Text :
- https://doi.org/10.1097/HS9.0000000000000193